Jennison Associates
DMTX

Jennison Associates’s Dimension Therapeutics, Inc DMTX Stock Holding History

Jennison Associates’s Portfolio DMTX Stock Details DMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-745,801
Closed -$5.83M – 684
2016
Q1 		$5.83M Buy
745,801
+3,347
+0.5% +$26.4K 0.01% 484
2015
Q4 		$8.27M Buy
+742,454
New +$9.4M 0.01% 492

Other funds holding DMTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates's DMTX Position: Q2 2016 in Review

Jennison Associates sold out of Dimension Therapeutics, Inc (DMTX) in Q2 2016, closing a stake of 745,801 shares — an estimated $5.83M sold.

Jennison Associates first reported a position in DMTX in Q4 2015 and held it in 2 quarters. The position peaked at $8.27M in Q4 2015. 52 funds tracked by Wall St. Rank hold DMTX as of Q2 2016.

  • Jennison Associates reported no remaining Dimension Therapeutics, Inc position as of Q2 2016 after selling out during the quarter.
  • Jennison Associates sold 745,801 Dimension Therapeutics, Inc shares in Q2 2016, an estimated $5.83M.
  • Jennison Associates first reported a position in Dimension Therapeutics, Inc in Q4 2015 and held it in 2 quarters.
  • Jennison Associates's Dimension Therapeutics, Inc position peaked at $8.27M in Q4 2015.
  • 52 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q2 2016.

Based on Jennison Associates's 13F filing for Q2 2016, filed 3 Aug 2016.